Teva Pharmaceutical Industries Ltd

GordonMD Global Investments LP TEVA
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/14/2026
Shares
2,402,495
Value ($000)
16,361
Weight
7.9%
2025 Q4 - 2026 Q2 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).